Business
Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing
Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n Sept. 8, 2023\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company – today announced the appointment of experienced medtech sales executive,\n \n Adam Hodges\n \n , as its Vice President, Sales and Marketing, effective immediately.\n \n \n \n \n \n \n \n \n \n \n Adrian Mendes\n \n , Perimeter's Chief Executive Officer stated, \"I am excited to welcome Adam to the Perimeter team as our senior leader responsible for the strategy and execution of our sales-related goals. Adam's extensive medtech background represents a great fit, with his focus on advancing category-first, novel technologies that challenge the clinical standard of care and add value to the healthcare system. We believe our market development managers and other team members in the field will benefit from his leadership as we expand the number of surgeon champions and geographical regions adopting our commercially available S-Series OCT medical imaging platform. Looking ahead, I expect Adam will also play a key role driving the expansion and adoption of our next-gen AI-enabled B-Series technology – which is currently in development – when it reaches a commercial roll-out stage.\"\n \n \n \n Adam Hodges\n \n brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in\n \n December 2022\n \n . During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice Presid...